Steward Partners Investment Advisory LLC Buys 13,215 Shares of American Healthcare REIT, Inc. (NYSE:AHR)

Steward Partners Investment Advisory LLC raised its stake in American Healthcare REIT, Inc. (NYSE:AHR - Free Report) by 109.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 25,241 shares of the company's stock after purchasing an additional 13,215 shares during the quarter. Steward Partners Investment Advisory LLC's holdings in American Healthcare REIT were worth $717,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Wilmington Savings Fund Society FSB acquired a new stake in American Healthcare REIT during the 3rd quarter worth approximately $28,000. GAMMA Investing LLC lifted its holdings in American Healthcare REIT by 104.1% during the 4th quarter. GAMMA Investing LLC now owns 988 shares of the company's stock worth $28,000 after purchasing an additional 504 shares during the last quarter. Carolina Wealth Advisors LLC acquired a new stake in American Healthcare REIT during the 4th quarter worth approximately $29,000. Richardson Capital Management LLC acquired a new stake in American Healthcare REIT during the 4th quarter worth approximately $29,000. Finally, Quarry LP acquired a new stake in American Healthcare REIT during the 3rd quarter worth approximately $33,000. 16.68% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts recently weighed in on AHR shares. JMP Securities set a $35.00 price target on American Healthcare REIT in a report on Tuesday, March 4th. Citigroup reissued an "outperform" rating on shares of American Healthcare REIT in a report on Tuesday, March 4th. Morgan Stanley raised their price objective on American Healthcare REIT from $27.00 to $29.00 and gave the stock an "overweight" rating in a research note on Monday, December 30th. Royal Bank of Canada raised their price objective on American Healthcare REIT from $28.00 to $30.00 and gave the stock an "outperform" rating in a research note on Monday, November 18th. Finally, Truist Financial raised their price objective on American Healthcare REIT from $27.00 to $29.00 and gave the stock a "buy" rating in a research note on Friday, November 15th. Eight equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company has a consensus rating of "Buy" and an average target price of $28.43.

Remove Ads

American Healthcare REIT Trading Up 3.0 %

Shares of AHR stock opened at $28.79 on Wednesday. The firm has a market capitalization of $4.54 billion and a P/E ratio of -59.97. American Healthcare REIT, Inc. has a twelve month low of $12.81 and a twelve month high of $30.97. The company has a quick ratio of 0.37, a current ratio of 0.37 and a debt-to-equity ratio of 0.59. The stock's fifty day simple moving average is $28.51 and its 200 day simple moving average is $26.87.

American Healthcare REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 17th. Investors of record on Tuesday, December 31st were given a dividend of $0.25 per share. The ex-dividend date was Tuesday, December 31st. This represents a $1.00 dividend on an annualized basis and a yield of 3.47%. American Healthcare REIT's dividend payout ratio is currently -370.37%.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.